New injection aims to help shed pounds in major obesity trial
NCT ID NCT07177469
Summary
This study is testing whether a new injectable medication called UBT251 can help people with overweight or obesity lose weight. About 205 participants will receive either the real injection or a placebo (a dummy shot with no medicine) for 24 weeks to see which is more effective and safe. The main goal is to see how much body weight changes, but researchers will also check effects on waist size, blood pressure, cholesterol, and mental health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.